Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Track medication changes and any new symptoms
Paul Gross, a physician specializing in diabetes, weight management and metabolic dysfunction
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK as Mounjaro for the treatment of type 2 diabetes mellitus and as Zepbound for weight management in adults with obesity or overweight with weight-related comorbidities (BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity)
Exposure to UV rays or even strong indoor lighting over time can degrade the peptide
US$ 20.86
US$ 25.79
US$ 25.40
US$ 28.43
US$ 25.56
US$ 27.17
US$ 24.50
US$ 27.42
US$ 22.39
